Skip to main content
. 2023 Jan 27;41(4):769–784. doi: 10.5534/wjmh.220200

Table 2. Major AE profiles of ARSI and taxane.

Agent Abiraterone Enzalutamide Apalutamide Darolutamide Docetaxel Cabazitaxel
Major AEs Fluid retention Fall/Fracture Fall/Fracture Fatigue Alopecia Diarrhea
Hepatic disorders Fatigue Fatigue Change in taste Fatigue
Hypertension Hot flashes Hypothyroidism Diarrhea Infection
Hypokalemia Hypertension Rash Fatigue Neutropenia
Nail changes
Neutropenia
Peripheral edema
Sensory neuropathy
Stomatitis
Clinical trial COU-AA-301 [5] AFFIRM [7] TITAN [21] ARAMIS [28] TAX 327 [3] TROPIC [9]
COU-AA-302 [6] PREVAIL [8] SPARTAN [26] CHAARTED [19] CARD [12]
LATITUDE [20] ENZAMET [22]
STAMPEDE [38] ARCHES [23]
PROSPER [27]

AE: adverse event, ARSI: androgen receptor-signaling inhibitor.